RYAN Ryan Specialty

• $5.6M bought by 6 insiders
• $235M sold by 4 insiders outside a trading plan
• None no planned (10b5-1) sales

1. Insider
   Trade
   Value
   Traded, filed
2. Brendan Martin Mulshine Co-President and CRO
   Sale
   $1.6M 40,000 shares at $40.51 35% of stake
   Traded Sep 8 Filed Sep 9
   ↗
3. Michael Conklin EVP & CHRO
   Sale
   $86K 2,043 shares at $42.26 20% of stake
   Traded Aug 13 Filed Aug 14
   ↗
4. Anthony J Kuczinski Director
   Buy
   $105K 3,000 shares at $34.99 +30% to stake
   Traded Jun 11–12 Filed Jun 15
   ↗
5. John W Rogers Jr. Director
   Buy
   $264K 7,500 shares at $35.16 +6.8% to stake
   Traded Jun 10 Filed Jun 11
   ↗
6. Patrick G Ryan Chair
   Buy
   $3.9M 120,000 shares at $32.50 +0.9% to stake
   Traded Jun 5 Filed Jun 8
   ↗
7. Janice M Hamilton CFO
   Buy
   $200K 6,300 shares at $31.79 +76% to stake
   Traded Jun 3 Filed Jun 4
   ↗
8. Mark Stephen Katz EVP & General Counsel
   Buy
   $100K 3,215 shares at $31.07 +288% to stake
   Traded Jun 3 Filed Jun 4
   ↗
9. Patrick G Ryan Jr. Director
   Buy
   $1M 25,865 shares at $39.98
   Traded Feb 20–23 Filed Feb 24
   ↗
10. Timothy William Turner CEO
    Sale
    $6.9M 129,570 shares at $53.61 91% of stake
    Traded Dec 12, 2025 Filed Dec 15, 2025
    ↗
11. Onex Corp. Director, +4 joint filers
    Sale
    $226M 4,145,621 shares at $54.50 100% of stake
    Traded Dec 5, 2025 Filed Dec 5, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 10 stock grants, 6 gifts, 3 option exercises, 2 conversions, 2 share withholdings for taxes, and 2 other transactions.